Literature DB >> 18194818

New G-protein-coupled receptor crystal structures: insights and limitations.

Brian Kobilka1, Gebhard F X Schertler.   

Abstract

G-protein-coupled receptors (GPCRs) constitute a large family of structurally similar proteins that respond to a chemically diverse array of physiological and environmental stimulants. Until recently, high-resolution structural information was limited to rhodopsin, a naturally abundant GPCR that is highly specialized for the detection of light. Non-rhodopsin GPCRs for diffusible hormones and neurotransmitters have proven more resistant to crystallography approaches, possibly because of their inherent structural flexibility and the need for recombinant expression. Recently, crystal structures of the human beta(2) adrenoceptor have been obtained using two different approaches to stabilize receptor protein and increase polar surface area. These structures, together with the existing structures of rhodopsin, represent an important first step in understanding how GPCRs work at a molecular level. Much more high-resolution information is needed for this important family of membrane proteins, however: for example, the structures of GPCRs from different families, structures bound to ligands having different efficacies, and structures of GPCRs in complex with G proteins and other signaling molecules. Methods to characterize the dynamic aspects of the GPCR architecture at high resolution will also be important.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194818     DOI: 10.1016/j.tips.2007.11.009

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  91 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

2.  Structural insights into human GPCR protein OA1: a computational perspective.

Authors:  Anirban Ghosh; Uddhavesh Sonavane; Sai Krishna Andhirka; Gopala Krishna Aradhyam; Rajendra Joshi
Journal:  J Mol Model       Date:  2011-09-22       Impact factor: 1.810

3.  Retinal dynamics underlie its switch from inverse agonist to agonist during rhodopsin activation.

Authors:  Andrey V Struts; Gilmar F J Salgado; Karina Martínez-Mayorga; Michael F Brown
Journal:  Nat Struct Mol Biol       Date:  2011-01-30       Impact factor: 15.369

Review 4.  Toward the fourth dimension of membrane protein structure: insight into dynamics from spin-labeling EPR spectroscopy.

Authors:  Hassane S McHaourab; P Ryan Steed; Kelli Kazmier
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

5.  Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins.

Authors:  Hak Jun Kim; Stanley C Howell; Wade D Van Horn; Young Ho Jeon; Charles R Sanders
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-11-01       Impact factor: 9.795

6.  Coupling of retinal, protein, and water dynamics in squid rhodopsin.

Authors:  Eduardo Jardón-Valadez; Ana-Nicoleta Bondar; Douglas J Tobias
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 7.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 8.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

9.  Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints.

Authors:  Viktor Hornak; Shivani Ahuja; Markus Eilers; Joseph A Goncalves; Mordechai Sheves; Philip J Reeves; Steven O Smith
Journal:  J Mol Biol       Date:  2009-12-11       Impact factor: 5.469

10.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.